⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Official Title: A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of BGB-3111, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Study ID: NCT03206970

Interventions

Zanubrutinib

Study Description

Brief Summary: The primary objective of this study was to evaluate the efficacy of zanubrutinib in participants with centrally confirmed relapsed or refractory MCL.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Beijing Cancer Hospital, Beijing, Beijing, China

Peking Union Medical College Hospital, Beijing, Beijing, China

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Henan Cancer Province, Zhengzhou, Henan, China

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

The First Affiliated Hospital of Jinlin University, Chang chun, Jilin, China

Fudan University Cancer Center, Shanghai, Shanghai, China

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

Tianjin Cancer Hospital, Tianjin, Tianjin, China

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Contact Details

Name: Study Director

Affiliation: BeiGene

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: